2012Unpublished venueRequires access

Expression of RRIG1 gene mRNA in breast carcinoma and its clinicopathologic significance

XU Xiao-chun

Open publisher page 0 citations

Abstract

Purpose To investigate the expression of RRIG1 mRNA and their relationships with clinicopathologic characters in breast carcinoma.Methods Real time quantitative reverse transcription polymerase chain reaction(RQ RT-PCR) technique was applied for detecting RRIG1 mRNA expression in 76 cases of breast carcinoma,5 cases of ductal carcinoma in situ and 20 cases of breast benign lesions.Results The level of mRNA expression of RRIG1 gene was significantly higher in breast benign 1esions(10.2±6.5) than in ductal carcinoma in situ(3.5±2.1) and invasive breast carcinoma(6.7±4.1)(P=0.004 and 0.036,respectively).RRIG1 mRNA expression is significantly lower in lymph node positive(5.2±3.1) than in non lymph node negative cases(7.48±4.5)(P=0.023).Conclusions RRIG1 may play a important role in disease occurrence and progression of breast carcinoma,RRIG1 may be a new biomarker for early diagnosis and prognosis in breast cancer.

About this research paper

What this paper is about

Purpose To investigate the expression of RRIG1 mRNA and their relationships with clinicopathologic characters in breast carcinoma.Methods Real time quantitative reverse transcription polymerase chain reaction(RQ RT-PCR) technique was applied for detecting RRIG1 mRNA expression in 76 cases of breast carcinoma,5 cases of ductal carcinoma in situ and 20 cases of breast benign lesions.Results The level of mRNA expression of RRIG1 gene was significantly higher in breast benign 1esions(10.2±6.5) than in ductal carcinoma in situ(3.5±2.1) and invasive breast carcinoma(6.7±4.1)(P=0.004 and 0.036,respectively).RRIG1 mRNA expression is significantly lower in lymph node positive(5.2±3.1) than in non lymph node negative cases(7.48±4.5)(P=0.023).Conclusions RRIG1 may play a important role in disease occurrence and progression of breast carcinoma,RRIG1 may be a new biomarker for early diagnosis and prognosis in breast cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Purpose To investigate the expression of RRIG1 mRNA and their relationships with clinicopathologic characters in breast carcinoma.Methods Real time quantitative reverse transcription polymerase chain reaction(RQ RT-PCR) technique was applied for detecting RRIG1 mRNA expression in 76 cases of breast carcinoma,5 cases of ductal carcinoma in situ and 20 cases of breast benign lesions.Results The level of mRNA expression of RRIG1 gene was significantly higher in breast benign 1esions(10.2±6.5) than in ductal carcinoma in situ(3.5±2.1) and invasive breast carcinoma(6.7±4.1)(P=0.004 and 0.036,respectively).RRIG1 mRNA expression is significantly lower in lymph node positive(5.2±3.1) than in non lymph node negative cases(7.48±4.5)(P=0.023).Conclusions RRIG1 may play a important role in disease occurrence and progression of breast carcinoma,RRIG1 may be a new biomarker for early diagnosis and prognosis in breast cancer.

Key concepts: Breast cancer, Breast carcinoma, Ductal carcinoma, Messenger RNA, Pathology, Lymph node, Carcinoma, Reverse transcription polymerase chain reaction

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of RRIG1 gene mRNA in breast carcinoma and its clinicopathologic significance — Research Paper | ScholarLens